The CD3-Zeta Chimeric Antigen Receptor Overcomes TCR Hypo-Responsiveness of Human Terminal Late-Stage T Cells

• Gunter Rappl ,

  Contributed equally to this work with: Gunter Rappl, Tobias Riet

  * E-mail: gunter.rappl@uni-koeln.de

  Affiliations Tumor Genetics, Dept. I Internal Medicine, University of Cologne, Cologne, Germany, Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany

  ⨯
• Tobias Riet ,

  Contributed equally to this work with: Gunter Rappl, Tobias Riet

  Affiliation Tumor Genetics, Dept. I Internal Medicine, University of Cologne, Cologne, Germany

  ⨯
• Sabine Awerkiew,

  Affiliation Institute for Virology, University of Cologne, Cologne, Germany

  ⨯
• Annette Schmidt,

  Affiliation Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany

  ⨯
• Andreas A. Hombach,

  Affiliation Tumor Genetics, Dept. I Internal Medicine, University of Cologne, Cologne, Germany

  ⨯
• Herbert Pfister,

  Affiliations Institute for Virology, University of Cologne, Cologne, Germany, Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany

  ⨯
• Hinrich Abken

  Affiliations Tumor Genetics, Dept. I Internal Medicine, University of Cologne, Cologne, Germany, Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany

  ⨯